Language:

Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses

The Lancet (British edition), 2019-03, Vol.393 (10174), p.899-909 [Peer Reviewed Journal]

2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2019. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2019 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31877-4 ;PMID: 30773280

Full text available

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses
Author: Ovadia, Caroline ; Seed, Paul T ; Sklavounos, Alexandros ; Geenes, Victoria ; Di Ilio, Chiara ; Chambers, Jenny ; Kohari, Katherine ; Bacq, Yannick ; Bozkurt, Nuray ; Brun-Furrer, Romana ; Bull, Laura ; Estiú, Maria C ; Grymowicz, Monika ; Gunaydin, Berrin ; Hague, William M ; Haslinger, Christian ; Hu, Yayi ; Kawakita, Tetsuya ; Kebapcilar, Ayse G ; Kebapcilar, Levent ; Kondrackienė, Jūratė ; Koster, Maria P H ; Kowalska-Kańka, Aneta ; Kupčinskas, Limas ; Lee, Richard H ; Locatelli, Anna ; Macias, Rocio I R ; Marschall, Hanns-Ulrich ; Oudijk, Martijn A ; Raz, Yael ; Rimon, Eli ; Shan, Dan ; Shao, Yong ; Tribe, Rachel ; Tripodi, Valeria ; Yayla Abide, Cigdem ; Yenidede, Ilter ; Thornton, Jim G ; Chappell, Lucy C ; Williamson, Catherine
Subjects: Acids ; Alanine ; Alanine transaminase ; Alanine Transaminase - blood ; Aspartate Aminotransferases - blood ; Babies ; Bias ; Bile ; Bile acids ; Bile Acids and Salts - blood ; bile-acid levels ; Bilirubin - blood ; Biochemical markers ; Biochemistry ; Biomarkers - blood ; Case reports ; Case-Control Studies ; Cholestasis ; Cholestasis, Intrahepatic - blood ; Cholestasis, Intrahepatic - epidemiology ; Clinical trials ; Cohort Studies ; Data analysis ; Data processing ; Female ; fetal outcomes ; Health risk assessment ; Humans ; Infant, Newborn ; Liver ; Markers ; Meta-analysis ; mortality ; Obstetrics, Gynecology and Reproductive Medicine ; Perinatal Death ; Population studies ; Pregnancy ; Pregnancy complications ; Pregnancy Complications - blood ; Pregnancy Complications - epidemiology ; Premature birth ; Premature Birth - blood ; Premature Birth - epidemiology ; Prospero protein ; Pruritus ; Randomized Controlled Trials as Topic ; Regression analysis ; Reproduktionsmedicin och gynekologi ; risk ; Risk analysis ; Risk Factors ; ROC Curve ; stillbirth ; Stillbirth - epidemiology ; Subgroups ; Systematic review ; women ; Womens health
Is Part Of: The Lancet (British edition), 2019-03, Vol.393 (10174), p.899-909
Description: Intrahepatic cholestasis of pregnancy is associated with adverse perinatal outcomes, but the association with the concentration of specific biochemical markers is unclear. We aimed to quantify the adverse perinatal effects of intrahepatic cholestasis of pregnancy in women with increased serum bile acid concentrations and determine whether elevated bile acid concentrations were associated with the risk of stillbirth and preterm birth. We did a systematic review by searching PubMed, Web of Science, and Embase databases for studies published from database inception to June 1, 2018, reporting perinatal outcomes for women with intrahepatic cholestasis of pregnancy when serum bile acid concentrations were available. Inclusion criteria were studies defining intrahepatic cholestasis of pregnancy based upon pruritus and elevated serum bile acid concentrations, with or without raised liver aminotransferase concentrations. Eligible studies were case-control, cohort, and population-based studies, and randomised controlled trials, with at least 30 participants, and that reported bile acid concentrations and perinatal outcomes. Studies at potential higher risk of reporter bias were excluded, including case reports, studies not comprising cohorts, or successive cases seen in a unit; we also excluded studies with high risk of bias from groups selected (eg, a subgroup of babies with poor outcomes were explicitly excluded), conference abstracts, and Letters to the Editor without clear peer review. We also included unpublished data from two UK hospitals. We did a random effects meta-analysis to determine risk of adverse perinatal outcomes. Aggregate data for maternal and perinatal outcomes were extracted from case-control studies, and individual patient data (IPD) were requested from study authors for all types of study (as no control group was required for the IPD analysis) to assess associations between biochemical markers and adverse outcomes using logistic and stepwise logistic regression. This study is registered with PROSPERO, number CRD42017069134. We assessed 109 full-text articles, of which 23 studies were eligible for the aggregate data meta-analysis (5557 intrahepatic cholestasis of pregnancy cases and 165 136 controls), and 27 provided IPD (5269 intrahepatic cholestasis of pregnancy cases). Stillbirth occurred in 45 (0·91%) of 4936 intrahepatic cholestasis of pregnancy cases and 519 (0·32%) of 163 947 control pregnancies (odds ratio [OR] 1·46 [95% CI 0·73–2·89]; I2=59·8%). In singleton pregnancies, stillbirth was associated with maximum total bile acid concentration (area under the receiver operating characteristic curve [ROC AUC]) 0·83 [95% CI 0·74–0·92]), but not alanine aminotransferase (ROC AUC 0·46 [0·35–0·57]). For singleton pregnancies, the prevalence of stillbirth was three (0·13%; 95% CI 0·02–0·38) of 2310 intrahepatic cholestasis of pregnancy cases in women with serum total bile acids of less than 40 μmol/L versus four (0·28%; 0·08–0·72) of 1412 cases with total bile acids of 40–99 μmol/L (hazard ratio [HR] 2·35 [95% CI 0·52–10·50]; p=0·26), and versus 18 (3·44%; 2·05–5·37) of 524 cases for bile acids of 100 μmol/L or more (HR 30·50 [8·83–105·30]; p<0·0001). The risk of stillbirth is increased in women with intrahepatic cholestasis of pregnancy and singleton pregnancies when serum bile acids concentrations are of 100 μmol/L or more. Because most women with intrahepatic cholestasis of pregnancy have bile acids below this concentration, they can probably be reassured that the risk of stillbirth is similar to that of pregnant women in the general population, provided repeat bile acid testing is done until delivery. Tommy's, ICP Support, UK National Institute of Health Research, Wellcome Trust, and Genesis Research Trust.
Publisher: England: Elsevier Ltd
Language: English
Identifier: ISSN: 0140-6736
EISSN: 1474-547X
DOI: 10.1016/S0140-6736(18)31877-4
PMID: 30773280
Source: ProQuest One Psychology
AUTh Library subscriptions: ProQuest Central
MEDLINE

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses

Searching Remote Databases, Please Wait